NEW YORK (Reuters Health) – Patients with acute migraine who find sumatriptan ineffective may have a better response to rizatriptan, according to a study reported in Cephalalgia online…
NEW YORK (Reuters Health) – For women of normal weight or moderate overweight who develop gestational diabetes late in pregnancy, treatment with metformin may be a suitable alternative…
NEW YORK (Reuters Health) – Augmenting antipsychotic treatment with a biologically active natural product, L-theanine, improves symptoms in patients with schizophrenia or schizoaffective disorder, Israeli investigators have shown…
NEW YORK (Reuters Health) – Hydroxychloroquine may reduce the heightened risk of cardiovascular disease in patients with rheumatoid arthritis. Use of hydroxychloroquine to treat rheumatoid arthritis is associated…
NEW YORK (Reuters Health) – Results of a meta-analysis indicate that moderate doses of inhaled corticosteroids do not have any clinically relevant advantage over low doses in children…
NEW YORK (Reuters Health) – Contrary to growing concerns, the incidence of coronary artery aneurysms after implantation of drug-eluting stents is low, and when an aneurysm does occur…
NEW YORK (Reuters Health) – In the short term, cryoablation for atrioventricular nodal reentrant tachycardia (AVNRT) is as effective as radiofrequency catheter ablation, but 6-month recurrence rates are…
NEW YORK (Reuters Health) – Among very low birth weight (VLBW) preterm infants, those treated with oral ibuprofen for patent ductus arteriosus have higher rates of closure than…
NEW YORK (Reuters Health) – The tumor volume threshold of 0.5 mL for clinically insignificant prostate cancer, established in the early 1990s, remains valid, according to researchers who…
NEW YORK (Reuters Health) – Anemia that develops in hepatitis C virus (HCV) patients during treatment with peginterferon-alfa and ribavirin (PEG-IFN/RBV) may be a good sign, new research…